InMed Pharmaceuticals Inc.

INM · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$2-$2-$2-$3
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$0-$0$0-$0
Other Non-Cash$0$0$0$0
Operating Cash Flow-$2-$2-$2-$3
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$0-$0-$0-$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$4$3$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$4-$0-$0
Financing Cash Flow-$0$8$3$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$2$6$1-$2
Supplemental Information
Beg. Cash$11$5$3$6
End Cash$9$11$5$3
Free Cash Flow-$2-$2-$2-$3